Codes ATC:
L01BA01
EMLc
Indication
Acute myeloid leukaemia with recurrent genetic abnormalities
Code ICD11:
2B30.0
INN
Methotrexate
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
50 mg in vial (as sodium salt) ;
50 mg per 2 mL ;
1000 mg per 10 mL concentrated injection
Oral > Solid: 2.5 mg (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the inclusion of additional dose forms of methotrexate (Injection: 50 mg/2 mL and Concentrated injection: 1000 mg/10 mL) to the EML and EMLc.